Made in India Hanooman AI has been launched to compete with ChatGPT and Google Gemini AI. The Indian company 3AI Holding and Seetha Mahalaxmi Healthcare (SML) introduced this AI tool in February this year. This AI tool, based on the Indian Large Language Model (LLM), has now become available for users. The special thing about this tool is that questions can be asked in 12 Indian languages. In addition to this, the tool also supports 98 global languages.
The Hanooman AI tool is currently available for free to all users. The company has announced this AI tool through its official social media handle. In its post, the company has said, "Say hello to Hanooman, India's very own Generative AI, breaking through language barriers effortlessly! Experience the magic of seamless communication in your preferred language like never before! Whether it's Hindi, Tamil, Bengali, or any other language, Hanooman has got you covered!"
Features of Hanooman AI
Hanooman AI has been designed for many critical sectors, such as healthcare, governance, financial services and education. Supporting 12 Indian languages and 98 global languages, users will be able to use this AI tool in their favorite language. This homegrown tool also works like ChatGPT and Google Gemini AI. If you ask any question in it, it will answer like a human.
The company said that specialized LLM has been used in this tool, which is integrated with the synthesis matrix. It enables clear, adaptive insights and seamless complex data transformation. This indigenous AI tool is currently available in the Alpha version, which means it is still in its very early stages.
How to use?
To use it, you have to go to its website https://www.hanooman.ai/. After this, you will have to log in with your mobile number or Gmail/LinkedIn account. After creating an account, you will be able to use this tool. The information in this has been updated till April 10, 2022. This tool is not currently giving real-time based answers.
ALSO READ: What if advanced AI goes into wrong hands? Potential risks and researchers' concerns explained
